Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms

被引：1
|
作者：
Schoenbeck, Kelly L. [1 ]
Salmasi, Giselle [2 ]
Cerejo, Miguel Carlos [2 ]
Cornett, Patricia A. [2 ]
Damon, Lloyd E. [2 ]
Logan, Aaron C. [2 ]
Olin, Rebecca L. [2 ]
Leavitt, Andrew D. [2 ]
Smith, Catherine C. [2 ]
机构：
[1] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Hematol & Blood & Marrow Transplantat, San Francisco, CA 94143 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1165
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients
    Joan How
    Charlotte Story
    Siyang Ren
    Donna Neuberg
    Rachel P. Rosovsky
    Gabriela S. Hobbs
    Jean M. Connors
    Blood Cancer Journal, 11
  • [32] Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms
    Koyuncu, Mahmut B.
    Cavusoglu, Cagatay
    Basir, Hakan
    Ilgan, Mustafa
    Ucar, Mehmet A.
    Akdeniz, Aydan
    Tombak, Anil
    Tiftik, Eyup N.
    Temel, Gulhan O.
    Neselioglu, Salim
    Erel, Ozcan
    CLINICAL LABORATORY, 2021, 67 (12) : 2700 - 2706
  • [33] Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients
    How, Joan
    Story, Charlotte
    Ren, Siyang
    Neuberg, Donna
    Rosovsky, Rachel P.
    Hobbs, Gabriela S.
    Connors, Jean M.
    BLOOD CANCER JOURNAL, 2021, 11 (11)
  • [34] The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
    Chia, Yuh Cai
    Islam, Md Asiful
    Hider, Phil
    Woon, Peng Yeong
    Johan, Muhammad Farid
    Hassan, Rosline
    Ramli, Marini
    CANCERS, 2021, 13 (12)
  • [35] Bone Marrow Stroma Protects BCR-ABL-Negative Myeloproliferative Neoplasms from Ruxolitinib- and Vorinostat-Induced Apoptosis
    Cardoso, Bruno A.
    Belo, Helio
    Oliveira, Ana Isabel
    Pereira, Olga
    Barata, Joao T.
    Almeida, Antonio
    BLOOD, 2014, 124 (21)
  • [36] Risk-adapted treatment of chronic BCR-ABL1 negative myeloproliferative neoplasms
    Heidel, Florian H.
    Doehner, Konstanze
    ONKOLOGE, 2019, 25 (11): : 985 - 993
  • [37] Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms
    Davidson, Marta
    Wong, Florence
    Atri, Mostafa
    Sibai, Hassan
    Maze, Dawn
    Cheung, Verna
    Callum, Jeannie
    Atenafu, Eshetu G.
    Gupta, Vikas
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : E88 - E90
  • [38] Chinese Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes
    Liang, Fengting
    Zou, Yangyang
    Huang, Liangmei
    Pang, Dongxiao
    JinbaoPang, Xuelan
    Liang, Xuelan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025,
  • [39] Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL -Negative Myeloproliferative Neoplasms
    Wille, Kai
    Deventer, Eva
    Sadjadian, Parvis
    Becker, Tatjana
    Kolatzki, Vera
    Huenerbein, Karlo
    Meixner, Raphael
    Jimenez-Munoz, Marina
    Fuchs, Christiane
    Griesshammer, Martin
    HAMOSTASEOLOGIE, 2024, 44 (05): : 386 - 392
  • [40] Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy
    Griesshammer, Martin
    Sadjadian, Parvis
    Wille, Kai
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (09) : 697 - 706
12345